Právní předpis byl sestaven k datu 20.06.2026.
Zobrazené znění právního předpisu je účinné od 10.05.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016
261/2015 Sb.
261
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze dne 22. září 2015
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2016
Xxxxxxxxxxxx zdravotnictví xxxxx §80 odst. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx x o xxxxx některých souvisejících xxxxxx, xx znění xxxxxxxxxx předpisů, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2016:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX):
Xxxxxxxxxxx xxxxxxxxxx1 xx méně xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani xxxxxxxxxx1 xx xxxx než 40 mezinárodních xxxxxxxx (XX)
Xxxxxxxx Bordetelly xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 mikrogramů
Pertactinum1 8 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx B2,3 10 xxxxxxxxxx
Xxxxx poliomyelitis (inaktivovaný)
typus 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx antigenu
Haemophilus xxxxxxxxxx typus x xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx xxxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Poliomyelitidis (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxx X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxx b xxxxxxxxxxxxxxx 12 mikrogramů
(Polyribosylribitoli xxxxxxxx)
xxxxxxxxx cum xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):
Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx&xxxx;≥ 40 mezinárodních jednotek
Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
XXXX
1xx) Xxxxxxxx látka proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (acelulární)
|
1 xxxxx (0,5 ml) xxxxxxxx: |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxxxxxxx anatoxinum |
|
|
Tetani xxxxxxxxxx |
Xxxxxxxxx 20 XX* (5 Lf) |
|
Pertusové xxxxxxxx |
|
|
Xxxxxxxxx xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx filamentosum |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxxxxx, xxxx 2 et 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx fosforečnan xxxxxxx |
1,5 xx (0,33 xx hliníku) |
NEBO
1bb) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx
Xxxxxxxxxxx anatoxinum1 ne xxxx xxx 2 xxxxxxxxxxx jednotky (IU) (2,5 Lf)
Tetani xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx antigena:
Pertussis xxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1
8 xxxxxxxxxx
Xxxxxxxxx membranae xxxxxxxx proteinum1 2,5 xxxxxxxxxx
1 adsorbováno xx xxxxxxxxxxx xxxxxxxx xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+ a xxxxxxxxxxx xxxxxxx (XXXX4) 0,2 xxxxxxxxx AI3+
1c) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx xxxxxxxxxx |
xxx. 30 mezinárodních xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (PT) |
25 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) |
25 xxxxxxxxxx |
|
Xxxxxxxxxxx (69kD) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx influenzae X |
10 xxxxxxxxxx |
|
xxx anatoxino xxxxxxxx |
20-40 xxxxxxxxxx |
1x) xxxxxxxx látka xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae xxx x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx ... xxx. 40 mezinárodních xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X od 16 xxx a xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
Xxxxxxxxxxx xxxxx xxxxxxxxxx (RIT 4385) xxx. 103,7 infekční xxxxx pro xxxxxxxx xxxxxxx50
Xxxxxxxx virus xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1x) xxxxxxxx látka xxxxx dětské xxxxxxxx xxxxx v xxxxxxxxxxxx xxxxx:
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ......... 8 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ...... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx vhodné imunochemické xxxxxx.
1xx) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9V, 10A, 11X, 12F, 14, 15X, 17X, 18C, 19X, 19X, 20, 22X, 23X, 33X ... 25 mikrogramů x xxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 3
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 4
Pneumococcale xxxxxxxxxxxxxxx sérotypus 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6B
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 7F
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxxx anatoxinum |
ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xx xxxx než 20 xxxxxxxxxxxxx jednotek |
Pertusové xxxxxxxx:
|
Xxxxxxxxx xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 mikrogramů |
Virus xxxxxxxxxxxxxxx xxxxxxxxxxx:
|
xxxxx 1 (xxxx Xxxxxxx) |
40 X xxxxxxxx antigenu |
|
typus 2 (xxxx MEF-1) |
8 X xxxxxxxx xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
32 X xxxxxxxx xxxxxxxx |
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxx toxoid |
více nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx) |
|
Xxxxxxxxx xxxxxx |
xxxx nebo rovno 20 mezinárodních xxxxxxxx (5 Xx) |
Xxxxxxxxx antigeny:
|
Pertusový xxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
Xxxxxxx xxxx 2+3 |
5 xxxxxxxxxx |
|
Xxxxxxxxx |
3 mikrogramy |
-
|
Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx typu 2 (xxxxxxxxxxxx) |
8 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) |
32 antigenních X xxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:
Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (XXX) xxxxxxx Xxxxxxx 1331.....0,75 xx
&xx;2,0 x 106 ≤ 8,0 x 106 XXX (xxxxxx xxxxxxx)
1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xxx xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx AS04C xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx x 1 dávce
1n) Xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x dětské xxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X 10 xxxxxxxxxx v 0,5 xx xxxxxxxx
2. Xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:
Antigenum xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Xxxxxx rabies XX/XX 38&xxxx;1503-3X více xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx v 1 xxxxx (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx virové hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxxxxxx A xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx očkovacích látek xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx látka proti xxxxxx hepatitidě X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx hepatitis X inactivatum
V roce 2016 x ohledem xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx případnou xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx zákonů.
Ministr:
v x. XXXx. Policar x. x.
xxxxxxxx xxx xxxxxxxxxxx x xxxxx
Informace
Právní xxxxxxx č. 261/2015 Sb. xxxxx xxxxxxxxx xxxx 24.10.2015.
Ve xxxxx xxxxxx xxxxxxxx xxxxxxxx jsou xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
131/2016 Sb., kterým xx xxxx xxxxxxx x. 261/2015 Xx., x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, zvláštní x xxxxxxxxx xxxxxxxx xxx xxx 2016
x xxxxxxxxx xx 10.5.2016
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx xx jich xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.